Adage Capital Partners
ALPN

Adage Capital Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Adage Capital Partners’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-310,000
Closed -$12.3M – 966
2024
Q1 		$12.3M Sell
310,000
-404,590
-57% -$11.9M 0.02% 563
2023
Q4 		$13.6M Buy
+714,590
New +$9.93M 0.03% 530

Adage Capital Partners's ALPN Position: Q2 2024 in Review

Adage Capital Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 310,000 shares — an estimated $12.3M sold.

Adage Capital Partners first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $13.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Adage Capital Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Adage Capital Partners sold 310,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $12.3M.
  • Adage Capital Partners first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • Adage Capital Partners's Alpine Immune Sciences Inc position peaked at $13.6M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Adage Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.